The Lancet1 个月
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.